ACCÈS RAPIDE AUX LIENS
TREML2 (triggering receptor expressed on myeloid cells-like 2), also known as C6orf76 or TLT2, is a 321 amino acid single-pass type I membrane protein that contains one Ig-like V-type domain. Expressed in cultured B cells, as well as in T cell leukemia and monocyte leukemia, TREML2 functions as a cell surface receptor that is thought to play a role in the innate and adaptive immune responses. The gene encoding TREML2 maps to a region on human chromosome 6 that is shared by proteins which contain Ig variavle (IgV) domains. Chromosome 6 contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps TREML2 (E-12) | sc-390363 | 200 µg/ml | $316.00 | |||
TREML2 (E-12): m-IgG Fc BP-HRP Kit | sc-540790 | 200 µg Ab; 10 µg BP | $354.00 | |||
TREML2 (E-12): m-IgG1 BP-HRP Kit | sc-542371 | 200 µg Ab; 20 µg BP | $354.00 | |||
TREML2 (E-12) peptide neutralisant | sc-390363 P | 100 µg/0.5 ml | $68.00 |